Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke

被引:10
作者
Gao, Qun [1 ,2 ]
Qi, Peng [1 ]
Wang, Junjie [1 ]
Hu, Shen [1 ]
Yang, Ximeng [1 ]
Fan, Jingwen [1 ,3 ]
Li, Ling [4 ,5 ]
Lu, Yao [4 ,5 ]
Lu, Jun [1 ,2 ]
Chen, Juan [4 ,5 ]
Wang, Daming [1 ,2 ]
机构
[1] Beijing Hosp, Natl Ctr Gerontol, Dept Neurosurg, 1 DaHua Rd, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[3] Peking Univ, Beijing Hosp, Sch Clin Med 5, Beijing, Peoples R China
[4] Beijing Hosp, Natl Ctr Gerontol, Dept Radiol, Beijing, Peoples R China
[5] Beijing Hosp, Natl Ctr Gerontol, Beijing Inst Geriatr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Thrombus; Type 2 diabetes mellitus; Admission hyperglycemia; Ultrastructure; Clot perviousness; PLATELET ACTIVATION; CONTRACTION; MECHANICS; SUBTYPE;
D O I
10.1186/s12883-022-02660-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Type 2 diabetes mellitus (T2DM) affects the occurrence and prognosis of acute ischemic stroke (AIS). However, the impact of diabetes on thrombus characteristics is unclear. The relationship between the composition and ultrastructure of clots and DM with admission hyperglycemia was investigated. Methods Consecutive patients with AIS who underwent endovascular thrombus retrieval between June 2017 and May 2021 were recruited. The thrombus composition and ultrastructure were evaluated using Martius scarlet blue stain and scanning electron microscopy. Clot perviousness was evaluated via thrombus attenuation increase on computed tomography angiography (CTA) versus non-contrast CT. Patients with admission hyperglycemia DM (ahDM) and those without DM (nonDM) were compared in terms of thrombus composition, ultrastructure, and perviousness. Results On admission, higher NIHSS scores (17 vs. 12, respectively, p = 0.015) was evident in ahDM patients. After the 90-day follow-up, the rates of excellent outcomes (mRS 0-1) were lower in patients with ahDM (16.6%, p = 0.038), but functional independence (mRS 0-2) and handicapped (mRS 3-5) were comparable between patients with ahDM and nonDM. The outcome of mortality was higher in patients with ahDM (33.3%, p = 0.046) than in nonDM patients. Clots in patients with ahDM had more fibrin (39.4% vs. 25.0%, respectively, p = 0.007), fewer erythrocyte components (21.2% vs. 41.5%, respectively, p = 0.043), equivalent platelet fraction (27.7% vs. 24.6%, respectively, p = 0.587), and higher WBC counts (4.6% vs. 3.3%, respectively, p = 0.004) than in nonDM patients. The percentage of polyhedral erythrocytes in thrombi was significantly higher in ahDM patients than in nonDM patients (68.9% vs. 45.6%, respectively, p = 0.007). The proportion of pervious clots was higher in patients nonDM than in patients with ahDM (82.61% vs. 40%, respectively, p = 0.026). Conclusion Patients with ahDM presented with greater stroke severity on admission and poorer functional outcomes after 3 months. Clots in patients with ahDM had more fibrin, leucocytes, and fewer erythrocyte components than in patients nonDM. The content of polyhedral erythrocytes and impervious clots proportion were significantly higher in thrombi of patients with AIS and ahDM. Further research is required to validate these findings.
引用
收藏
页数:10
相关论文
共 43 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity [J].
Ajjan, Ramzi A. ;
Gamlen, Toby ;
Standeven, Kristina F. ;
Mughal, Salihah ;
Hess, Katharina ;
Smith, Kerrie A. ;
Dunn, Emma J. ;
Anwar, M. Maqsud ;
Rabbani, Naila ;
Thornalley, Paul J. ;
Philippou, Helen ;
Grant, Peter J. .
BLOOD, 2013, 122 (01) :134-142
[3]   Classification and Diagnosis of Diabetes [J].
不详 .
DIABETES CARE, 2015, 38 :S8-S16
[4]   Clot permeability and histopathology: is a clot's perviousness on CT imaging correlated with its histologic composition? [J].
Benson, John Charles ;
Fitzgerald, Sean T. ;
Kadirvel, Ramanathan ;
Johnson, Collin ;
Dai, Daying ;
Karen, Doyle ;
Kallmes, David F. ;
Brinjikji, Waleed .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (01) :38-42
[5]   PLATELET AND COAGULATION-FACTORS IN PROLIFERATIVE DIABETIC-RETINOPATHY [J].
BORSEY, DQ ;
PROWSE, CV ;
GRAY, RS ;
DAWES, J ;
JAMES, K ;
ELTON, RA ;
CLARKE, BF .
JOURNAL OF CLINICAL PATHOLOGY, 1984, 37 (06) :659-664
[6]   Platelet contractile force (PCF) and clot elastic modulus (CEM) are elevated in diabetic patients with chest pain [J].
Carr, ME ;
Krishnaswami, A ;
Martin, EJ .
DIABETIC MEDICINE, 2002, 19 (10) :862-866
[7]   Erythrocyte Fraction Within Retrieved Thrombi Contributes to Thrombolytic Response in Acute Ischemic Stroke [J].
Choi, Mun Hee ;
Park, Geun Hwa ;
Lee, Jin Soo ;
Lee, Sung Eun ;
Lee, Seong-Joon ;
Kim, Jang-Hee ;
Hong, Ji Man .
STROKE, 2018, 49 (03) :652-659
[8]   Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin [J].
Cines, Douglas B. ;
Lebedeva, Tatiana ;
Nagaswami, Chandrasekaran ;
Hayes, Vincent ;
Massefski, Walter ;
Litvinov, Rustem I. ;
Rauova, Lubica ;
Lowery, Thomas J. ;
Weisel, John W. .
BLOOD, 2014, 123 (10) :1596-1603
[9]   Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients [J].
Etalamy, I. ;
Chakroun, T. ;
Gerotziafas, G. T. ;
Petropoulou, A. ;
Robert, F. ;
Karroum, A. ;
Elgrably, F. ;
Samama, M. -M. ;
Hatmi, M. .
THROMBOSIS RESEARCH, 2008, 121 (06) :843-848
[10]   Diabetes mellitus as a prothrombotic condition [J].
Grant, P. J. .
JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) :157-172